Trivalent genetic reassortant rotavirus vaccine (Lanzhou Institute of Biological Products)

Ⅲ价轮状病毒基因重配疫苗（兰州生物制品研究所）

Report date: 2023/11/01 10:33:30

Base Information

Drug NameTrivalent genetic reassortant rotavirus vaccine (Lanzhou Institute of Biological Products)
Drug Alias NameRotavirus vaccine trivalent ( Lanzhou Institute of Biological Products)
ClassificationVaccines > Vaccine type > Multivalent vaccineVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsGastroenteritisRotavirus Infections
Global Approved IndicationsRotavirus Infections
Approved Indications in ChinaRotavirus Infections
Original Approved Country/TerritoryMainland China
Original Approved Date2023/04/17
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesLanzhou Institute Of Biological Products Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesLanzhou Institute Of Biological Products Co Ltd
Inactive CompaniesN/A
Active IndicationsRotavirus Infections
Inactive IndicationsGastroenteritis

Other Information

ATC CodeN/A
Related LinksN/A